Crossmark

Immune Checkpoint Inhibitors and Interstitial Lung Disease: A Comprehensive Review of Pathogenesis, Diagnosis, and Management

Crossref DOI link: https://doi.org/10.1016/j.opresp.2026.100578

Published Print: 2026-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pilia, María Florencia

Felip, Enriqueta

Espejo, David

Pardo, Nuria

Andreu Casas, Marta

Clofent, David

Villar, Ana

Ojanguren, Iñigo
Funding

Funding for this research was provided by:

Boehringer Ingelheim

Roche

Vall d'Hebron Research Institute
License Information

Text and Data Mining valid from 2026-04-01

Text and Data Mining valid from 2026-04-01

Version of Record valid from 2026-01-13
More Information

This article is maintained by: Elsevier

Article Title: Immune Checkpoint Inhibitors and Interstitial Lung Disease: A Comprehensive Review of Pathogenesis, Diagnosis, and Management

Journal Title: Open Respiratory Archives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.opresp.2026.100578

Content Type: article

Copyright: © 2026 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.